Search for Sanofi and
    1. August 22, 2016

      Pfizer makes $14bn bet on cancer drugmaker Medivation

      Pfizer unveiled its biggest takeover of a cancer company in its 167-year history on Monday — the $14bn acquisition of...

    2. August 22, 2016

      Pfizer/Medivation: combination therapy

      There is a grim symmetry between the challenges pharmaceutical companies face and the treatments they sell. Both are...

    Special Reports

    1. FT Health: Vaccines

      In today’s connected world, where outbreaks of infectious disease can spread faster th...
    2. Health: Emerging Markets

      From the rising scourge of diabetes to the Ebola epidemic, responses around the world ...
    Search more Special Reports on this topic.

    1. Fast FT

      July 29, 2016

      Sanofi Q2 profits fall as sales of Lantus insulin suffer

      Sales and profits at Sanofi, the French drugmaker currently in pursuit of US cancer drug developer Medivation, dropped...

    2. July 6, 2016

      Medivation: scarcity value

      One must be a careful about criticising big pharma companies for splashing the cash on smaller, essentially one-product...

    3. July 6, 2016

      Medivation confident drugs pipeline will win over suitors

      After two years of furious dealmaking in the pharmaceuticals industry, large drugmakers have started to complain there...

    4. July 5, 2016

      Medivation agrees to $10bn takeover talks

      Medivation, the US biotech company, has agreed to hold talks about a $10bn sale with large global pharmaceutical groups...

    5. Fast FT

      July 5, 2016

      Medivation agrees to $10bn sale talks with Sanofi

      US biotech company Medivation has agreed to hold talks with Sanofi, France’s largest pharma group, about a potential...

    6. June 2, 2016

      M&A back on the table as ‘big pharma’ targets smaller rivals

      After a start to the year marred by an accounting scandal at Valeant, the collapse of Pfizer’s $160bn merger with...

    7. May 25, 2016

      Sanofi seeks to oust entire Medivation board

      Pharmaceuticals group Sanofi is trying to ram through its $9.3bn proposed takeover offer of Medivation by launching a...

    8. Fast FT

      May 25, 2016

      Sanofi seeks to replace Medivation's board in sale tussle

      French drugmaker Sanofi is seeking to replace the whole of Medivation’s board. Sanofi, which has threatened to go...

    9. May 19, 2016

      Pull together to prevent a superbug apocalypse

      Jim O’Neill, UK Treasury minister and former Goldman Sachs economist, has focused the world’s attention on...

    10. May 5, 2016

      Sanofi threatens to go hostile in $9.3bn pursuit of Medivation

      Sanofi has threatened to oust the board of Medivation if the US biotech company continues to resist its $9.3bn takeover...

    11. Fast FT

      May 5, 2016

      Sanofi threatens to go hostile in Medivation battle

      French drugmaker Sanofi has been sounding out shareholders in Medivation, the US pharmaceuticals group behind the...

    12. Fast FT

      May 4, 2016

      Private equity closes in on $7.5bn deal for MultiPlan

      Maurice “Hank” Greenberg, the 90-year-old former chief executive of AIG, is close to possibly tripling a $1.4bn...

    13. April 29, 2016

      M&A: back with a bang

      Consider it an M&A explosion that even Jack Lew, US Treasury secretary, could love. Out of the ether, $60bn worth of...

    14. Fast FT

      April 29, 2016

      Medivation rejects Sanofi's $9.3bn takeover offer

      Medivation has rejected an unsolicited $9.3bn takeover proposal from Sanofi of France as analysts predicted that...

    15. April 29, 2016

      AstraZeneca cuts costs for shift to cancer drugs

      AstraZeneca has launched a $1.1bn cost-cutting plan to accelerate its shift from mass-market primary care products to a...

    16. April 28, 2016

      Three pharma deals worth $45bn reignite M&A boom

      A trio of deals worth a combined $45bn breathed fresh life into the healthcare mergers and acquisitions boom on...

    17. April 28, 2016

      AbbVie joins wave of pharma moves with Stemcentrx deal

      AbbVie has agreed to buy Stemcentrx, a biotech company focused on cancer, in a deal worth up to $10bn, making it the...

    18. April 28, 2016

      Sanofi makes $9.3bn unsolicited cash offer for Medivation

      Sanofi, France’s largest pharma group, unveiled on Thursday an unsolicited $9.3bn bid to buy US biotech company...

    19. Fast FT

      April 28, 2016

      Sanofi goes public with unsolicited bid for Medivation

      It looks as though things could be turning hostile in the latest round of global pharmaceuticals M&A. French drugmaker...

    20. April 25, 2016

      Vaccines are among big pharma’s best-selling products

      Ask people to name Pfizer’s best-selling product and many would opt for one of its most famous drugs: Viagra, for...

    21. April 25, 2016

      Race for universal flu vaccine gathers pace

      Every year millions of people head to their doctors’ surgeries to roll up their sleeves and receive their annual flu...

    22. April 15, 2016

      Sanofi wins WHO support for dengue fever vaccine

      Sanofi has won backing from World Health Organisation experts for its dengue fever vaccine, providing an important...

    23. April 4, 2016

      Sanofi to launch dengue mass vaccination programme

      Sanofi will launch the world’s first mass vaccination programme for dengue fever in the Philippines on Monday, bringing...

    24. Fast FT

      March 30, 2016

      Medivation hires bankers to defend against takeover

      Medivation has hired bankers to defend itself from a potential takeover bid, after the US drugmaker was approached by a...

    25. Fast FT

      March 30, 2016

      Eurozone bond yields hit fresh lows

      Some eurozone government bond yields have dropped to fresh record lows this morning, driven down by another slathering...

    26. Fast FT

      March 29, 2016

      Sanofi poaches immunology expert from AstraZeneca

      French drugmaker Sanofi has poached the head of research at AstraZeneca’s biologics research and development arm,...

    27. Fast FT

      March 10, 2016

      Sanofi plucks new chief medical officer from Novartis

      French drugmaker Sanofi has plucked a new senior executive from rival Swiss healthcare group Novartis. Dr Ameet...

    28. Fast FT

      March 8, 2016

      Sanofi, Merck to end European vaccine venture

      A rare example of pharmaceutical companies parting ways. French drugmaker Sanofi and America’s Merck are scrapping a...

    29. February 28, 2016

      Sanofi eyes acquisitions in market for rare disease drugs

      Sanofi is open to acquisitions in the market for rare disease treatments in a sign of confidence that the high prices...

    30. February 9, 2016

      Sanofi upbeat on prospects for heart drug despite slow start in US

      An important new heart drug that Sanofi is counting on to help revive growth is still on course for blockbuster sales,...

    31. Fast FT

      February 9, 2016

      Allerject recall drags down Sanofi's Q4 sales

      A recall of Allerject, a treatment for serious allergic reactions, in the US and Canada wiped €122m off fourth-quarter...

    32. February 4, 2016

      Norway’s oil fund steps up pressure on multinationals

      Norway’s $810bn oil fund has revealed that it voted against proposals from some of the world’s biggest companies —...

    33. Fast FT

      February 4, 2016

      Norway's oil fund sells 73 stakes on sustainability concerns

      Norway’s $810bn oil fund sold out of 73 companies last year due to environmental and governance issues as the world’s...

    34. February 2, 2016

      Sanofi leads hunt for Zika vaccine

      Sanofi is ready to take a leading role in the hunt for a vaccine to combat Zika virus after it became the first...

    35. January 21, 2016

      Drugmakers call for collective action on superbugs

      Most of the world’s biggest pharmaceuticals groups have backed a declaration committing the industry to help tackle...

    36. January 11, 2016

      Sanofi unveils €1.2bn of deals as part of push into cancer drugs

      Sanofi has signed two deals with biotech companies worth up to €1.2bn in a clear sign of the French pharmaceuticals...

    37. December 18, 2015

      Week in Review, December 19

      A round up of some of the week’s most significant corporate events and news stories. Aveva stock slides as time takes...

    38. December 16, 2015

      Pharmaceutical groups turn to asset swaps to boost growth

      The proposed €18bn asset swap between Sanofi and Boehringer Ingelheim this week highlights the rise of “precision M&A”...

    Search for Sanofi and


    Videos from that closely match this topic

    1. Lex discusses the turmoil at the French drugmaker...
      October 29, 2014

      Lex discusses the turmoil at the French drugmaker